Urinary Activin A as Apredictive Marker for Assessement of Acute Kidney Injury Severity in Patient Admitted at Assuit University Hospital

Launched by ASSIUT UNIVERSITY · Dec 19, 2023

Keywords

ClinConnect Summary

This clinical trial is investigating a substance called urinary Activin A to see if it can help doctors understand how severe acute kidney injury (AKI) is in patients admitted to Assuit University Hospital. Acute kidney injury is a sudden decrease in kidney function, which can happen for various reasons, and knowing its severity is important for treatment. The study aims to find out if measuring urinary Activin A levels can be a reliable way to assess the seriousness of this condition.

To participate in this trial, individuals must be between the ages of 65 and 74 and have acute kidney injury without a history of chronic kidney disease. Unfortunately, those with certain health conditions, like heart failure or cancer, and pregnant women cannot join. Participants will undergo tests to measure their urinary Activin A levels, which could provide valuable information for their care. This study is still in the planning stages and has not started recruiting participants yet.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The study will include patient with acute kidney injury with no history of chronic kidney diseases
• Exclusion Criteria:
• • patient with history of chronic kidney diseases , diseases associated with icreased activin A level such as ( heart failure , cancers , COPD , systemic sclerosis ,pregnant , viral infection , and Mycosis Fungoides and Sézary Syndrom